MedPath

ART5803

Generic Name
ART5803
Drug Type
Biotech

Overview

ART5803 is a humanized one-armed monoclonal antibody with a high affinity for the NMDA receptor.

Background

ART5803 is a humanized one-armed monoclonal antibody with a high affinity for the NMDA receptor.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 1
Recruiting
Posted: 2024/12/31
Sponsor:
Arialys Therapeutics
Phase 1
Recruiting
Posted: 2024/08/28
Sponsor:
Arialys Therapeutics

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath